Aerovate Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.77-4.85-2.13-2.60
Price/Sales ratio
N/A8.033.960.86
Earnings per Share (EPS)
$-1.51$-0.55$-1.25$-1.02

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-167.35-61.65-12.53-13.91-7.89-6.16-37.09
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-152.97-41.761.665.655.443.62-20.04
Price/Cash Flow ratio
-200.39-70.91-10.50-18.32-10.49-7.73-40.70
Price/Free Cash Flow ratio
-200.39-70.91-10.43-18.23-10.46-7.68-40.67
Price/Earnings Growth ratio
N/A-0.37-0.08-0.11-0.21-0.11-0.09
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-0.03%5.95%-0.01%-0.04%-0.07%-0.03%-0.02%
Return on Assets
-94.76%-191.70%-13.09%-38.07%-59.27%-54.99%-25.58%
Return On Equity
91.40%67.73%-13.31%-40.64%-68.99%-51.41%-26.98%
Return on Capital Employed
-116.59%-302.24%-13.32%-41.74%-74.15%-59.96%-27.53%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A16.89N/A
Quick Ratio
5.342.6368.3616.897.0416.6042.63
Cash ratio
5.342.5721.252.871.332.8712.06
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A223.38K29.39K13.82K9.10KN/A21.60K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.71N/A0.000.000.000.060.03
Debt Equity Ratio
-0.68N/A0.000.000.000.060.00
Long-term Debt to Capitalization
-2.18N/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
-2.18N/A0.000.000.000.000.00
Interest Coverage Ratio
N/AN/AN/AN/AN/A-114.30N/A
Cash Flow to Debt Ratio
-1.11N/A-142.70-101.61-135.18-54.42-98.56
Company Equity Multiplier
-0.96-0.351.011.061.161.060.33
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111.001.001.001.001.00
Cash Flow Coverage Ratio
-1.11N/A-142.70-101.61-135.18-54.42-98.56
Short Term Coverage Ratio
N/AN/A-142.70-101.61-135.18-154.07-122.15
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A